WuXi STA Launches High Potency Sterile Injectable Manufacturing Line in China
The new HP injectable manufacturing line, with an annual capacity of 12 million units, enhances the company’s manufacturing capabilities and capacity for injectable dosage forms.
WuXi STA | 19/07/2023 | By Manvi | 556
WuXi STA adds peptide manufacturing capacity at Changzhou campus
With two new 2,000L reactors the total reactor volume of the Solid Phase Peptide Synthesizers at WuXi TIDES has increased to over 10,000 litres
WuXi STA | 08/05/2023 | By Sudeep Soparkar | 455
WuXi STA opens oral solids continuous manufacturing line
Operation has begun for CRDMO WuXi STA’s first continuous manufacturing line for oral solids, in Wuxi city, China
<br />
WuXi STA | 05/01/2023 | By Sudeep Soparkar | 442
WuXi STA opens new manufacturing facility
WuXi STA opens new large-scale Oligonucleotide and Peptide manufacturing facility
WuXi STA | 08/07/2022 | By Sudeep Soparkar | 341
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy